SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252800
Filing Date
2017-08-09
Accepted
2017-08-09 16:16:58
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d419258d10q.htm 10-Q 344463
2 EX-31.1 d419258dex311.htm EX-31.1 8997
3 EX-31.2 d419258dex312.htm EX-31.2 8903
4 EX-32.1 d419258dex321.htm EX-32.1 4048
5 EX-32.2 d419258dex322.htm EX-32.2 4033
  Complete submission text file 0001193125-17-252800.txt   2590073

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20170630.xml EX-101.INS 447770
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20170630.xsd EX-101.SCH 38511
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20170630_cal.xml EX-101.CAL 46425
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20170630_def.xml EX-101.DEF 115675
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20170630_lab.xml EX-101.LAB 287082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20170630_pre.xml EX-101.PRE 201364
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 171018159
SIC: 2834 Pharmaceutical Preparations